APHIS, IN COOPERATION WITH FSIS AND FDA, CONDUCTS AN ONGOING BSE SURVEILLANCE PROGRAM IN ACCORDANCE WITH THE ANIMAL HEALTH PROTECTION ACT (7 USC CH. 109). THE ONGOING SURVEILLANCE PROGRAM REQUIRES BRAIN STEM SAMPLES TO BE COLLECTED FROM CATTLE IN THE